Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles.

Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles.
复制标题

DOI:
10.1002/smll.200800646
复制
发表时间:
2009-02
期刊:
影响因子:
13.3
通讯作者:
Zhang, Miqin
Zhang, Miqin
中科院分区:
材料科学1区
文献类型:
--
作者:
Veiseh, Omid;Gunn, Jonathan W.;Kievit, Forrest M.;Sun, Conroy;Fang, Chen;Lee, Jerry S. H.;Zhang, Miqin

文献摘要

参考文献

被引文献

相似文献

Nanoparticles have been investigated as drug delivery vehicles, contrast agents, and multifunctional devices for patient care. Current nanoparticle-based therapeutic strategies for cancer treatment have been mainly based on delivery of chemotherapeutic agents to induce apoptosis or DNA/siRNA to regulate oncogene expression. Here, we present a nanoparticle system that demonstrates an alternative approach to the treatment of cancers, through the inhibition of cell invasion, while serving as a magnetic resonance and optical imaging contrast agent. The nanoparticle is comprised of an iron oxide nanoparticle core, conjugated with an amine-functionalized PEG silane and a small peptide, chlorotoxin (CTX), which enables the tumor cell-specific binding of the nanoparticle. We show that the nanoparticle exhibits substantially enhanced cellular uptake and an invasion inhibition rate of ~98% compared to unbound CTX (~45%). Significantly, our investigation from flow cytometry analysis, transmission electron microscopy and fluorescent imaging revealed that the CTX-enabled nanoparticles deactivated the membrane-bound matrix metalloproteinase 2 (MMP-2) and induced increased internalization of lipid rafts that contain surface-expressed MMP-2 and volume-regulating ion channels through receptor-mediated endocytosis, leading to enhanced prohibitory effects. Since upregulation and activity of MMP-2 have been observed in tumors of neuroectodermal origin, and in cancers of the breast, colon, skin, lung, prostate, ovaries and a host of others, this nanoparticle system can be potentially used for non-invasive diagnosis and treatment of a variety of cancer types.
DOI: 10.1158/0008-5472.can-06-3948
发表时间: 2007-07-15
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Veiseh, Mandana;Gabikian, Patrik;Olson, James M.
通讯作者: Olson, James M.
DOI: 10.1038/nm1101-1241
发表时间: 2001-11-01
期刊: NATURE MEDICINE
影响因子: 82.9
作者:
Zhao, M;Beauregard, DA;Brindle, KM
通讯作者: Brindle, KM
DOI: 10.1021/jm060515m
发表时间: 2006-10-05
影响因子: 7.3
作者:
Montet, Xavier;Funovics, Martin;Josephson, Lee
通讯作者: Josephson, Lee
DOI: 10.1002/smll.200700784
发表时间: 2008-03-01
期刊: SMALL
影响因子: 13.3
作者:
Sun, Conroy;Veiseh, Omid;Zhang, Miqin
通讯作者: Zhang, Miqin
DOI: 10.1038/73219
发表时间: 2000-03-01
期刊: Nature Medicine
影响因子: 82.9
作者:
Weissleder, Ralph;Moore, Anna;Basilion, James P.
通讯作者: Basilion, James P.